BackgroundSoluble amyloid-β (Aβ) oligomers are the major toxic substances associated with the pathology of Alzheimer’s disease (AD). The ability to measure Aβ oligomer levels in the blood would provide simple and minimally invasive tools for AD diagnostics. In the present study, the recently developed Multimer Detection System (MDS) for AD, a new enzyme-linked immunosorbent assay for measuring Aβ oligomers selectively, was used to detect Aβ oligomers in the plasma of patients with AD and healthy control individuals.MethodsTwenty-four patients with AD and 37 cognitively normal control individuals underwent extensive clinical evaluations as follows: blood sampling; detailed neuropsychological tests; brain magnetic resonance imaging; cerebrospinal fluid (CSF) measurement of Aβ42, phosphorylated tau protein (pTau), and total tau protein (tTau); and 11C-Pittsburgh compound B (PIB) positron emission tomography. Pearson’s correlation analyses between the estimations of Aβ oligomer levels by MDS and other conventional AD biomarkers (CSF Aβ42, pTau, and tTau, as well as PIB standardized uptake value ratio [PIB SUVR]) were conducted. ROC analyses were used to compare the diagnostic performance of each biomarker.ResultsThe plasma levels of Aβ oligomers by MDS were higher in patients with AD than in normal control individuals, and they correlated well with conventional AD biomarkers (levels of Aβ oligomers by MDS vs. CSF Aβ42, r = −0.443; PIB SUVR, r = 0.430; CSF pTau, r = 0.530; CSF tTau, r = 0.604). The sensitivity and specificity of detecting plasma Aβ oligomers by MDS for differentiating AD from the normal controls were 78.3% and 86.5%, respectively. The AUC for plasma Aβ oligomers by MDS was 0.844, which was not significantly different from the AUC of other biomarkers (p = 0.250).ConclusionsPlasma levels of Aβ oligomers could be assessed using MDS, which might be a simple, noninvasive, and accessible assay for evaluating brain amyloid deposition related to AD pathology.Electronic supplementary materialThe online version of this article (doi:10.1186/s13195-017-0324-0) contains supplementary material, which is available to authorized users.
Photocatalytic
water splitting, CO2 reduction, and pollutant
degradation have emerged as promising strategies to remedy the existing
environmental and energy crises. However, grafting of expensive and
less abundant noble-metal cocatalysts on photocatalyst materials is
a mandatory practice to achieve enhanced photocatalytic performance
owing to the ability of the cocatalysts to extract electrons efficiently
from the photocatalyst and enable rapid/enhanced catalytic reaction.
Hence, developing highly efficient, inexpensive, and noble-metal-free
cocatalysts composed of earth-abundant elements is considered as a
noteworthy step toward considering photocatalysis as a more economical
strategy. Recently, MXenes (two-dimensional (2D) transition-metal
carbides, nitrides, and carbonitrides) have shown huge potential as
alternatives for noble-metal cocatalysts. MXenes have several excellent
properties, including atomically thin 2D morphology, metallic electrical
conductivity, hydrophilic surface, and high specific surface area.
In addition, they exhibit Gibbs free energy of intermediate H atom
adsorption as close to zero and less than that of a commercial Pt-based
cocatalyst, a Fermi level position above the H2 generation
potential, and an excellent ability to capture and activate CO2 molecules. Therefore, there is a growing interest in MXene-based
photocatalyst materials for various photocatalytic events. In this
review, we focus on the recent advances in the synthesis of MXenes
with 2D and 0D morphologies, the stability of MXenes, and MXene-based
photocatalysts for H2 evolution, CO2 reduction,
and pollutant degradation. The existing challenges and the possible
future directions to enhance the photocatalytic performance of MXene-based
photocatalysts are also discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.